Abrezekimab

Abrezekimab (VR 942) contains CDP7766, a humanized, high-affinity, neutralizing, anti-human-IL-13 antibody fragment that binds to IL-13. Abrezekimab prevents binding to the IL-13Rα1 subunit. Abrezekimab can be used in research of asthma.
Read more
€0.00 (tax incl.)
Reference:
HY-P99417
Product Details
HY-P99417

Data sheet

Size
Multiple sizes
Reactivity
Interleukin Related
CAS
2043952-59-4

Menu

Settings